Pharma exports fall in FY26; decline extends into Q1FY27
KARACHI: Pakistan’s pharmaceutical exports fell sharply in FY26 and continued to decline in the first quarter of FY27, as disruption of trade with Afghanistan, once one of the country’s major markets for medicines, weighed on the sector’s export performance. Pakistan exported pharmaceutical products worth USD319.012 million in FY26, down from USD457.456 million in FY25, according to Pakistan…
Pakistan's pharmaceutical exports experienced a sharp decline in FY26, falling to USD319.012 million from USD457.456 million in FY25, according to PBS data. The export volumes also decreased by 26.14 percent, from 112,517 tonnes to 83,104 tonnes. The decline continued into Q1FY27, with export earnings dropping to USD73.301 million from USD98.428 million in the same quarter of FY26, a decrease of USD25.127 million or 25.53 percent.
The quantity exported fell 31.40 percent, from 23,924 tonnes to 16,410 tonnes. The average declared export value per tonne rose by about 8.6 percent in the first quarter, from approximately USD4,115 to USD4,469, but fell by about 5.6 percent in FY26. The decline is attributed to the disruption of trade with Afghanistan, which was a major market for Pakistani medicines before the trade disruption.
Brief written by urgent.news from Business Recorder's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
